Diabetes drug metformin may cut risk of long COVID --research

Diabetes drug metformin may cut risk of long COVID - UPI.com Metformin cut the risk of long COVID by about 40% for patients who received a two-week course of the drug while battling their infection, the researchers reported. UPI

...

"This shows that 14 days of metformin treatment, when started early after infection, prevents diagnosis of long COVID over the subsequent 10 months," said lead researcher Dr. Carolyn Bramante, an assistant professor with the University of Minnesota Medical School, in Minneapolis.

...